Associate Professor Fazlul Huq

Associate Professor
Biomedical Sciences, School of Medical Sciences

Telephone +61 2 9351 9522
Fax +61 2 9351 9520

Map

Research interests

Designing tumour active compounds with wider spectrum of activity and reduced side effects and use of combination between phytochemicals and targeted therapy to overcome drug resistance

Teaching and supervision

A/Prof Fazlul Huq teaching toxicology, biochemistry and biophysics to students in the Faculty of Health Sciences

PhD and master's project opportunities

Selected grants

2014

  • CLARIOstar Multifunctional Microplate Reader for Shared Used at the Open Access, Multi-User Molecular Biology Core Facility; Huang M, Scolyer R, Fraser S, Sahni S, Speranza T, Owens T, Barrs V, Ju Y, Kovacevic Z, Lu Z, Camp A, Slobedman B, Morris B, Oliver B, Dos Remedios C, Kalinowski D, Fu D, Lai D, Lovicu F, Allbutt H, Triccas J, Burgess J, Kril J, Dixon K, Rendina L, Byrne M, King N, Groundwater P, Williamson P, Ho J, Dong Q, Bao B, Assinder S, McLennan S, Richardson D, Ammit A, Sharland A, Hardikar A, Hong A, Hambly B, Lee C, Murphy C, Goldsbury C, Johnstone D, Lane D, Hibbs D, Joshua D, Huq F, Halliday G, Sutherland G, Zreiqat H, Lok H, Lyons G, Jansson P, Black J, Zhu L, Sunde M, Day M, Naylor M, Buckland M, Murray M, Shafie N, Lay P, Poronnik P, Codd R, Mason R, Ryan R, Christopherson R, de Graaf S; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2013

  • Robotic High Throughput Western Analysis for the Open Access, Multi-User Sydney Cancer Research Core Facility; Richardson D, Scolyer R, Boyer M, Halliday G, Damian D, Christopherson R, Joshua D, Kench J, Hong A, Murray M, Lee C, Kalinowski D, Naylor M, Lay P, Lyons G, Kovacevic Z, Mason R, Dixon K, Chan-Ling T, Hawkins C, Sunde M, Lovejoy D, Owens T, Rendina L, Jansson P, Dos Remedios C, Charles (nee Slaviero) K, Lane D, Witting P, Dong Q, Ammit A, Groundwater P, Assinder S, Bao B, Byrne S, Zhou F, Buckland M, Grewal T, Huq F, Lai D, Codd R, Zhang D, Fu D, de Graaf S, Huang M, Payne R, Slobedman B, Barrs V, Ho J, Williamson P, Murphy C; DVC Research/Equipment Grant.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Huq, F., Beale, P., Yu, J. (2009). Studies on New Platinum Compounds. In Andrea Bonetti, Roberto Leone,Franco M Muggia, Stephen B Howell (Eds.), Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, (pp. 11-17). US: Humana Press.

Journals

  • Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCI(NH3)2u {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] CI4 in Human Ovarian Cancer Cells. Anticancer Research, 34(4), 1923-1929.
  • Yunos, N., Mutalip, S., Jauri, M., Yu, J., Huq, F. (2013). Anti-proliferative and Pro-apoptotic Effects from Sequenced Combinations of Andrographolide and Cisplatin on Ovarian Cancer Cell Lines. Anticancer Research, 33(10), 4365-4371. [More Information]
  • Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2013). Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumor models. Journal of Ovarian Research, 6(Nov 2013), 1-11. [More Information]
  • Lal, B., Badshah, A., Altaf, A., Tahir, M., Ullah, S., Huq, F. (2013). Study of new ferrocene incorporated N,N'-disubstituted thioureas as potential antitumour agents. Australian Journal of Chemistry: an international journal for chemical science, 66(11), 1352-1360. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2013). Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models. Medicinal Chemistry, 9(4), 539-544. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells. Anticancer Research, 32(1), 53-59. [More Information]
  • Mazumder, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Epigallocatechin Gallate Acts Synergistically in Combination with Cisplatin and Designed trans-palladiums in Ovarian Cancer Cells. Anticancer Research, 32(11), 4851-4860. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Studies on combination of platinum drugs Cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models. Anticancer Research, 32(11), 4843-4850. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Huq, F. (2012). Studies on the activity of two trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models. Anticancer Research, 32(12), 5331-5336. [More Information]
  • Hamad, S., Beale, P., Yu, J., Fisher, K., Huq, F. (2012). Synthesis and Activity of [{Cis-PtC1(NH3)2}2m{Trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]C14 in the human ovarian tumour models. Medicinal Chemistry, 8(3), 384-391. [More Information]
  • Mazumder, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Synthesis and Cytotoxicity of Three trans-Palladium Complexes Containing Planaramine Ligands in Human Ovarian Tumor Models. ChemMedChem: chemistry enabling drug discovery, 7(10), 1840-1846. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2012). Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models. Anticancer Research, 32(1), 135-140. [More Information]
  • Lal, B., Badshah, A., Altaf, A., Tahir, M., Ullah, S., Huq, F. (2012). Synthesis, characterization and antitumor activity of new ferrocene incorporated N,N′-disubstituted thioureas. Dalton Transactions: an international journal of inorganic, organometallic and bioinorganic chemistry, 41(48), 14643-14650. [More Information]
  • Al-Shuneigat, J., Mahgoub, S., Huq, F. (2011). Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study. Journal of Biomedical Science, 18(Article number 50), 50-1-50-5. [More Information]
  • Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2011). Modulation of Cisplatin Cytotoxicity due to its Combination with Bortezomib and the Nature of its Administration. Anticancer Research, 31(9), 2757-2762. [More Information]
  • Al-Shuneigat, J., Qing, Y., Beale, P., Fisher, K., Huq, F. (2011). Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3). Medicinal Chemistry, 7(1), 1-8. [More Information]
  • Alshehri, A., Beale, P., Yu, J., Huq, F. (2011). Synergism from Combination of Cisplatin and Multicentred Platinums Coded as DH6Cl and TH1 in the Human Ovarian Tumour Models. Medicinal Chemistry, 7(6), 593-598. [More Information]
  • Yunos, N., Beale, P., Yu, J., Huq, F. (2011). Synergism from Sequenced Combinations of Curcumin and Epigallocatechin-3-gallate with Cisplatin in the Killing of Human Ovarian Cancer Cells. Anticancer Research, 31(4), 1131-1140. [More Information]
  • Yunos, N., Beale, P., Yu, J., Huq, F. (2011). Synergism from the Combination of Oxaliplatin with Selected Phytochemicals in Human Ovarian Cancer Cell Lines. Anticancer Research, 31(12), 4283-4289. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2011). Synergism from Vombinations of Cisplatin and Oxaliplatin with Quercetin and Thymoquinone in Human Ovarian Tumour Models. Anticancer Research, 31(11), 3789-3797. [More Information]
  • Huq, F., Danish, M., Starosta, W., Leciejewicz, J. (2011). trans-Bis(3-hydroxypyridine-jN)- diiodidoplatinum(II) dimethyl sulfoxide disolvate. Acta Crystallographica. Section E: Structure Reports Online, 67(6), m721-sup-7. [More Information]
  • Yunos, N., Beale, P., Yu, J., Strain, D., Huq, F. (2010). Studies on combinations of platinum with Paclitaxel and colchicine in ovarian cancer cell lines. Anticancer Research, 30(10), 4025-4037. [More Information]
  • Al-Shuneigat, J., Yu, J., Beale, P., Fisher, K., Huq, F. (2010). Studies on Two New mixed Ligand Platinum Compounds with a Trans-Geometry. Medicinal Chemistry, 6(5), 321-328. [More Information]
  • Alshehri, A., Beale, P., Yu, J., Huq, F. (2010). Synergism from combination of Cisplatin and a trans-platinum compound in ovarian cancer cell lines. Anticancer Research, 30(11), 4547-4553. [More Information]
  • Farhad, M., Yu, J., Beale, P., Fisher, K., Huq, F. (2009). Studies on the synthesis and activity of three tripalladium complexes containing planaramine ligands. ChemMedChem: chemistry enabling drug discovery, 4(11), 1841-1849. [More Information]
  • Huq, F., Tayyem, H., Yu, J., Beale, P., Fisher, K. (2009). Synthesis, activity and binding with DNA of [{trans-PtCl(NH3)2}2mu-{trans-Pd(4-hydroxypyridine)2(H2N(CH2)6NH2)2]Cl4 (TH8). Medicinal Chemistry, 5(4), 372-381. [More Information]
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Ambroxol. Journal of Pharmacology and Toxicology, 3(2), 147-152.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Entecavir. Journal of Pharmacology and Toxicology, 3(1), 41-46.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Maraviroc. Asian Journal of Biochemistry, 3(2), 79-89.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Methimazole. Journal of Pharmacology and Toxicology, 3(1), 11-19.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Ramelteon. Journal of Pharmacology and Toxicology, 3(2), 119-126.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Rasagiline. Journal of Pharmacology and Toxicology, 3(2), 168-172.
  • Huq, F., Fasim, F. (2008). Molecular Modelling Analysis of The Metabolism of Strychnine. International Journal of Pure and Applied Chemistry, 3(4), 241-246.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Terbinafine. Journal of Pharmacology and Toxicology, 3(2), 64-74.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Udenafil. Asian Journal of Biochemistry, 3(2), 109-117.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Venlafaxine. Journal of Pharmacology and Toxicology, 3(1), 27-33.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Zolpidem. Journal of Pharmacology and Toxicology, 3(2), 93-101.
  • Tayyem, H., Huq, F., Yu, J., Beale, P., Fisher, K. (2008). Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH(3))(2)}(2)mu-{trans-Pt(3-hydroxypyridine)(2)(H(2)N(CH(2))(6)NH(2))(2)}]Cl(4) in ovarian cancer cell lines. ChemMedChem: chemistry enabling drug discovery, 3(1), 145-151. [More Information]
  • Huq, F. (2007). A Molecular Modelling Analysis of Luliconazole, Lanconazole and Bifonazole. Journal of Pharmacology and Toxicology, 2(6), 567-573.
  • Huq, F. (2007). A Molecular Modelling Analysis of the Metabolism of Mexiletine. Journal of Pharmacology and Toxicology, 2(7), 638-645.
  • Huq, F., Yunos, N. (2007). A Molecular Modelling Analysis of the Toxicity of Aflatoxin B1 and its Modulation by Chlorophyllin. International Journal of Pure and Applied Chemistry, 2(4), 371-376.
  • Huq, F. (2007). A Molecular Modelling Analysis of Toxicity of Fosamax and Risedronate. Journal of Pharmacology and Toxicology, 2(5), 489-495.
  • Huq, F. (2007). Metabolic Activation of Chloroform-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 37-42.
  • Huq, F. (2007). Metabolic Activation of Paracetamol-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 43-49.
  • Huq, F. (2007). Metabolic Activation of Toluene-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 105-120.
  • Huq, F. (2007). Metabolism of isoniazid – a molecular modelling analysis. International Journal of Pure and Applied Chemistry, 2(1), 1-9.
  • Huq, F. (2007). Metabolism of Ketoprofen-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(2), 229-234.
  • Huq, F. (2007). Metabolism of Mefenamic Acid-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 121-126.
  • Huq, F. (2007). Metabolism of Niclosamide-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 77-83.
  • Huq, F. (2007). Metabolism of vinyl chloride – a molecular modelling analysis. International Journal of Pure and Applied Chemistry, 2(1), 11-18.
  • Huq, F. (2007). Modular modelling analysis of the o-, m- and p-directing influences of substituents in electrophilic attack on aromatic compounds. Asian Journal of Chemistry, 19(1), 55-66.
  • Huq, F. (2007). Molecular modeling analysis of the metabolism of tarceva. International Journal of Pure and Applied Chemistry, 2(3), 281-287.
  • Huq, F. (2007). Molecular modelling analyses of the dimerization of acetic acid in non-polar solvents. Asian Journal of Chemistry, 19(1), 27-33.
  • Huq, F. (2007). Molecular Modelling Analyses of the Metabolism of Clofarabine. Journal of Pharmacology and Toxicology, 2(7), 599-609.
  • Huq, F. (2007). Molecular modelling analyses of the relative stability of alkenes, arenes and their epoxides and diols. Asian Journal of Chemistry, 19(1), 39-48.
  • Huq, F. (2007). Molecular Modelling Analysis of the Antioxidant Activity of Probucol. Asian Journal of Biochemistry, 2(5), 354-358.
  • Huq, F. (2007). Molecular Modelling Analysis of the Formation of HX.H2O Aggregates and (HX)n Oligomers where X = F, Cl, Br and I. International Journal of Pure and Applied Chemistry, 2(1), 19-25.
  • Huq, F., Ababneh, D. (2007). Molecular Modelling Analysis of the Metabolic Activation of Ethylene Glycol. Journal of Pharmacology and Toxicology, 2(1), 54-62.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Anagrelide. International Journal of Cancer Research, 3(1), 33-38.
  • Huq, F., Yunos, N. (2007). Molecular Modelling Analysis of the Metabolism of Andrographolide. International Journal of Pure and Applied Chemistry, 2(4), 359-369.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Aniracetam. Asian Journal of Biochemistry, 2(3), 164-171.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of aspirin. Asian Journal of Chemistry, 19(1), 102-108.
  • Huq, F., Ababneh, D., Alshehri, A. (2007). Molecular modelling analysis of the metabolism of carbamazepine. International Journal of Pure and Applied Chemistry, 2(2), 235-243.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of carbon tetrachloride. International Journal of Pure and Applied Chemistry, 2(1), 85-91.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Ceftiofur. Journal of Pharmacology and Toxicology, 2(4), 340-349.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Clotrimazole. Journal of Pharmacology and Toxicology, 2(8), 748-752.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Cocaine. Journal of Pharmacology and Toxicology, 2(2), 114-130.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of diflunisal. International Journal of Pure and Applied Chemistry, 2(2), 191-196.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of duloxetine. International Journal of Pure and Applied Chemistry, 2(3), 297-302.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Enoxacin. Journal of Pharmacology and Toxicology, 2(3), 284-289.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Eszopiclone. Journal of Pharmacology and Toxicology, 2(8), 732-736.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Fenbufen. Asian Journal of Biochemistry, 2(1), 50-57.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Fentanyl. Journal of Pharmacology and Toxicology, 2(2), 176-182.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Irbesartan. Journal of Pharmacology and Toxicology, 2(3), 238-247.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Latanoprost. Journal of Pharmacology and Toxicology, 2(4), 359-365.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of Loxapine. International Journal of Pure and Applied Chemistry, 2(2), 183-189.
  • Huq, F. (2007). Molecular modelling Analysis of the Metabolism of Lumiracoxib. International Journal of Pure and Applied Chemistry, 2(4), 377-385.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Mefenamic Acid. Journal of Pharmacology and Toxicology, 2, 72-79.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Meropenem. Journal of Pharmacology and Toxicology, 2(3), 295-299.
  • Huq, F., Al-Shuneigat, J. (2007). Molecular Modelling Analysis of the Metabolism of Methadone. Asian Journal of Biochemistry, 2(1), 19-30.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of methamphetamine. International Journal of Pure and Applied Chemistry, 2(1), 27-35.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of mifepristone. International Journal of Pure and Applied Chemistry, 2(2), 175-181.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of mirtazapine. International Journal of Pure and Applied Chemistry, 2(3), 289-296.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Naphthalene. Journal of Pharmacology and Toxicology, 2, 33-43.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of Nefazodone. International Journal of Pure and Applied Chemistry, 2(2), 155-165.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Paracetamol. Journal of Pharmacology and Toxicology, 2(2), 142-150.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of phenytoin. Journal of Pharmacology and Toxicology, 2(1), 63-71.
  • Huq, F., Al-Qassab, S. (2007). Molecular modelling analysis of the metabolism of raloxifene. International Journal of Pure and Applied Chemistry, 2(2), 197-204.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of scopolamine. International Journal of Pure and Applied Chemistry, 2(3), 271-280.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Tegaserod. Journal of Pharmacology and Toxicology, 2(5), 447-455.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Thiabendazole. Journal of Pharmacology and Toxicology, 2(6), 524-532.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Tolterodine. Journal of Pharmacology and Toxicology, 2(4), 319-327.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Toluene. Journal of Pharmacology and Toxicology, 2(1), 20-32.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of Trilostane. International Journal of Pure and Applied Chemistry, 2(4), 353-358.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Troglitazone. Asian Journal of Biochemistry, 2(4), 256-262.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Zileuton. International Journal of Pure and Applied Chemistry, 2(3), 263-269.
  • Huq, F. (2007). Structure of Hexakis(trimethylsilylmethyl)dimolybdenum: The First Compound Reported to have a Mo Mo Bond. Asian Journal of Chemistry, 19(1), 49-54.
  • Huq, F. (2006). A molecular modelling analysis of why DDT and its metabolites have prolonged persistence in the environment and the living systems. International Journal of Pure and Applied Chemistry, 1(2), 191-196.
  • Huq, F., Abdullah, A., Beale, P. (2006). Antitumour activity of cis-bis{imidazo(1,2-alpha)pyridineplatinum(II). International Journal of Cancer Research, 2(4), 367-375.
  • Farhad, M., Huq, F., Sivanandasingham, P. (2006). In vitro studies on DNA damage due to mixtures of ascorbate and iron(II). International Journal of Pure and Applied Chemistry, 1(2), 197-203.
  • Cheng, H., Chowdhury, A., Huq, F. (2006). Interaction between Ag+, nucleobases and nucleotides in solution. Asian Journal of Chemistry, 18(1), 37-44.
  • Huq, F. (2006). Metabolism of nicotine: a molecular modelling analysis. International Journal of Pure and Applied Chemistry, 1(3), 315-322.
  • Huq, F., Peter, M. (2006). Molecular mechanics and semi-empirical analyses of the interaction between Nickel(II) and L-histidine and L-arginine in solution in water. Asian Journal of Chemistry, 18(1), 45-49.
  • Huq, F., Peter, M. (2006). Molecular mechanics and semi-empirical analysis of the interaction between Co2+ and the amino acids in solution in water. Asian Journal of Chemistry, 18(1), 79-85.
  • Huq, F. (2006). Molecular modelling analysis of metabolism of styrene. International Journal of Pure and Applied Chemistry, 1(3), 371-378.
  • Huq, F. (2006). Molecular modelling analysis of the axial distortion of the coordination geometry around copper(II) in octahedral ligand fields. Asian Journal of Chemistry, 18(3), 1633-1636.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of adefovir dipivoxil. Journal of Pharmacology and Toxicology, 1(4), 362-368.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of caffeine. Asian Journal of Biochemistry, 1(4), 276-286.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of chloroform. Journal of Pharmacology and Toxicology, 1(5), 438-446.
  • Huq, F., Hossain, Z. (2006). Molecular modelling analysis of the metabolism of chlorpromazine. International Journal of Pure and Applied Chemistry, 1(1), 15-21.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of cocaine. International Journal of Pure and Applied Chemistry, 1(3), 323-330.
  • Huq, F., Al-Shuneigat, J. (2006). Molecular modelling analysis of the metabolism of codeine. Journal of Pharmacology and Toxicology, 1(5), 407-417.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of dacarbazine. International Journal of Pure and Applied Chemistry, 1(1), 31-36.
  • Huq, F., Hossain, Z. (2006). Molecular modelling analysis of the metabolism of diazepam. International Journal of Pure and Applied Chemistry, 1(1), 23-29.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of enrofloxacin. Asian Journal of Biochemistry, 1(4), 316-324.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of hydrazine. Journal of Pharmacology and Toxicology, 1(5), 485-489.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of ibuprofen. Journal of Pharmacology and Toxicology, 1(5), 456-463.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of isoniazid. Journal of Pharmacology and Toxicology, 1(5), 447-455.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of letrozole. International Journal of Cancer Research, 2(4), 403-408.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of maprotiline. Journal of Pharmacology and Toxicology, 1(6), 537-544.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of modafinil. Journal of Pharmacology and Toxicology, 1(4), 369-375.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of morphine. International Journal of Pure and Applied Chemistry, 1(3), 349-357.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of naltrexone. Journal of Pharmacology and Toxicology, 1(4), 354-361.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of naproxen. Journal of Pharmacology and Toxicology, 1(4), 346-353.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of niclosamide. Journal of Pharmacology and Toxicology, 1(4), 376-382.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of nitroimidazoles. International Journal of Pure and Applied Chemistry, 1(2), 147-153.
  • Huq, F., Hossain, Z. (2006). Molecular modelling analysis of the metabolism of pyrazinamide. Journal of Pharmacology and Toxicology, 1(6), 505-515.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of quazepam. International Journal of Pure and Applied Chemistry, 1(2), 141-146.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of sildenafil. International Journal of Pure and Applied Chemistry, 1(3), 339-347.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of sulindac. International Journal of Pure and Applied Chemistry, 1(2), 165-169.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of tamoxifen. International Journal of Pure and Applied Chemistry, 1(2), 155-163.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of topotecan. International Journal of Cancer Research, 2(4), 390-396.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of vinyl chloride. Journal of Pharmacology and Toxicology, 1(4), 299-316.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of zaleplon. Journal of Pharmacology and Toxicology, 1(4), 328-336.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of zebularine. Journal of Pharmacology and Toxicology, 1(4), 317-327.
  • Huq, F. (2006). Semi-empirical and DFT Analyses of the Metabolism of Hydrazine. International Journal of Pure and Applied Chemistry, 1(4), 455-459.
  • Huq, F., Farhad, M., Abdullah, A., Beale, P., Zhang, M. (2006). Studies on Oligonuclear Palladium Complexes. Asian Journal of Chemistry, 18(3), 1607-1625.
  • Huq, F., Tayyem, H., Beale, P., Yu, J. (2006). Studies on the activity of three palladium(II) compounds of the form: Trans-PdL(2)Cl(2) where L=2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine. Journal of Inorganic Biochemistry, 101(1), 30-35. [More Information]
  • Huq, F., Abdullah, A., Chowdhury, A., Tayyem, H., Beale, P., Fisher, K. (2006). Studies on the synthesis and characterization, and binding with DNA of two Cis-Planaramineplatinum(II) complexes of the forms: Cis-PtL2Cl2 and Cis-PtL(NH3)Cl2 and where L=3-hydroxypyridine and imidazo(1,2-αlpha) Pyridine. International Journal of Pure and Applied Chemistry, 1(1), 91-100.
  • Huq, F., Abdullah, A., Chowdhury, A., Cheng, H., Tayyem, H., Beale, P. (2006). Studies on the synthesis and characterization, binding with DNA and activity of cis-Bis{imidazo(1,2-alpha)-pyridine}dichloroplatinum(II). Asian Journal of Chemistry, 18(3), 1637-1648.
  • Huq, F., Abdullah, A., Beale, P., Yu, J., Zhang, M. (2006). Studies on the synthesis, characterization and binding with DNA of cis-bis (2,3-diaminopyridine) diiodoplatinum (II): A compound with high cell uptake and drug-DNA binding but very little activity. International Journal of Pure and Applied Chemistry, 1(2), 205-211.
  • Abdullah, A., Huq, F., Chowdhury, A., Tayyem, H., Beale, P., Fisher, K. (2006). Studies on the synthesis, characterization, binding with DNA and activities of two cis-planaramineplatinum(II) complexes of the form:cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine. BMC Chemical Biology, 6, 3-1-3-9. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Beale, P., Fisher, K. (2006). Syntheses and Characterisation of Four Trinuclear Complexes of The Form: [{Trans-Ptcl(NH3)2}2m-{Trans-Pd(NH3)2(H2N(CH2)Nnh2)2]Cl4 Where N = 4 to 7. International Journal of Pure and Applied Chemistry, 1(4), 493-507.
  • Huq, F., Tayyem, H., Abdullah, A., Beale, P., Fisher, K. (2006). Synthesis and Characterization and Binding of Amine-Palladium(II) Complexes and their Interaction with DNA. Asian Journal of Chemistry, 18(1), 65-78.
  • Cheng, H., Huq, F., Beale, P., Fisher, K. (2006). Synthesis, characterisation, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}2µ-{trans-Pd(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4. European Journal of Medicinal Chemistry, 41(7), 896-903. [More Information]
  • Huq, F., Hossain, Z. (2006). Vitamin C causes a much-pronounced damage to DNA in presence of Cd2+ but not in presence of Zn2+ or Ag+. Why? Asian Journal of Chemistry, 18(3), 1649-1658.
  • Cheng, H., Huq, F., Farhad, M. (2005). Interaction between Cu(II) and the neucleobases in solution. Asian Journal of Chemistry, 17(3), 1532-1538.
  • Huq, F. (2005). Molecular mechanics and semi-empirical analyses of the interaction between Cu(II) and amino acids in solution. Asian Journal of Chemistry, 17(3), 1550-1558.
  • Chowdhury, M., Huq, F., Abdullah, A., Beale, P., Fisher, K. (2005). Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the forms: trans-PtL2Cl2 and [PtL3Cl]Cl, where L = 3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-alpha)pyridine. Journal of Inorganic Biochemistry, 99(5), 1098-1112. [More Information]
  • Cheng, H., Huq, F., Beale, P., Fisher, K. (2005). Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}(2)mu-{trans-Pt(NH3)(2-hydroxypyridine)-(H2N(CH2)(6)NH2)(2)]Cl-4. European Journal of Medicinal Chemistry, 40(8), 772-781. [More Information]
  • Huq, F. (2005). Why the lower-membered alkanoic acids are infinitely soluble in water whereas the higher-membered ones have a low solubility in water? A molecular modeling analysis. Asian Journal of Chemistry, 17(2), 1001-1012.
  • Daghriri, H., Huq, F., Beale, P. (2004). 'Studies On Activities, Cell Uptake And Dna Binding Of Four Multinuclear Complexes Of The Form: [{Trans-Ptcl(Nh3)2}2U-{Trans-Pd(Nh3)2-(H2N(Ch2)Nnh2)2}]Cl4 Where N = 4-7'. Journal of Inorganic Biochemistry, 98(11), 1722-1733. [More Information]
  • Huq, F., Yu, J., Daghriri, H., Beale, P. (2004). Studies On Activities, Cell Uptake And Dna Binding Of Four Trans-Planaramineplatinum(Ii) Complexes Of The Form: Trans-Ptl(Nh3)Cl-2,Where L=2-Hydroxypyridine, Imidazole, 3-Hydroxypyridine And Imidazo(1,2-Alpha)Pyridine. Journal of Inorganic Biochemistry, 98(8), 1261-1270. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Beale, P., Fisher, K. (2004). Studies On The Synthesis And Characterization Of Four Trans-Planaramineplatinum(Ii) Complexes Of The Form Trans-Ptl(Nh3)Cl2 Where L = 2-Hydroxypyridine, 3-Hydroxypyridine, Imidazole, And Imidazo(1,2-Alpha)Pyridine. European Journal of Medicinal Chemistry, 39(8), 691-697. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Tayyem, H., Beale, P., Zhang, M. (2004). Synthesis, Characterisation, Activities, Cell Uptake And Dna Binding Of [{Trans-Ptcl(Nh3)2} {U-(H2N(Ch2)6Nh2)} {Trans-Pdcl(Nh3)2](No3)Cl. European Journal of Medicinal Chemistry, 39(11), 947-958. [More Information]
  • Huq, F., Yu, J. (2002). Molecular modeling analysis: "why is 2-hydroxypyridine soluble in water but not 3-hydroxypyridine?". Journal of Molecular Modeling, 8(3), 81-86. [More Information]
  • Hossain, Z., Huq, F. (2002). Studies on the interaction between Ag+ and DNA. Journal of Inorganic Biochemistry, 91(2), 398-404.
  • Hossain, Z., Huq, F. (2002). Studies on the interaction between Cd2+ and nucleobases and nucleotides. Journal of Inorganic Biochemistry, 90(3-4), 97-105.
  • Hossain, Z., Huq, F. (2002). Studies on the interaction between Cd2+ ions and DNA. Journal of Inorganic Biochemistry, 90(3-4), 85-96.
  • Huq, F. (2001). Molecular modeling analysis of the ease in oxidation of planar nickel-peptide complexes. Journal of Molecular Modeling, 7, 433-437.

Conferences

  • Ababneh, D., Oakes, D., Huq, F. (2006). Evaluation of the genotoxic potential of cadmium and vitamin C against purified plasmid DNA and cellular DNA. Australian Health and Medical Research Congress, Melbourne: Australian Health and Medical Research Congress.
  • Mousa, K., Mahajan, D., Huq, F., Bermingham, M. (2002). Body fat ratio and BMI in a group of Bangladeshi residents in Australia. From Cell to Society 3, : British Medical Journal Publishing Group.
  • Beale, P., Daghriri, H., Huq, F. (2002). Studies on anticancer active heteronuclear metal complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Abdullah, A., Beale, P., Huq, F. (2002). Studies on planaramineplatinum (II) complexes with cis-geometry. Third Research Conference 2002 From Cell to Society, : British Medical Journal Publishing Group.
  • Beale, P., Cheng, H., Huq, F. (2002). Studies on polynuclear complexes with different coordination geometries. From Cell to Society 3, : British Medical Journal Publishing Group.
  • Beale, P., Huq, F., Mohammad, F. (2002). Studies on polynuclear palladium complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Bibi, M., Huq, F., Sivanandasingham, P. (2002). Studies on the antioxidant and prooxidant behaviour of ascorbate in presence of iron. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Yu, J., Beale, P., Huq, F. (2002). Studies on transplanaramineplatinum (II) complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Mousa, K., Mahajan, D., Huq, F., Bermingham, M. (2002). The relationship between percent TBF and BMI in a Bangladeshi population sample in Australia. Proceedings of the Australian Health and Medical Research Congress 2002, : British Medical Journal Publishing Group.
  • Hossain, Z., Huq, F. (2001). Changes in adenine and adenine nucleotides due to their interaction with Cd2+ ions. Redox Processes in Chemistry, Biology and Medicine, : Ads & Adea.
  • Hossain, Z., Huq, F. (2001). Increased DNA damage due to cooperative interaction between Cd2+ and antioxidants. Redox Processes in Chemistry, Biology and Medicine, : Ads & Adea.
  • Huq, F., Mohammad, F. (2001). Modelling the interaction between Cu2+ and the nucleobases adenine and guanine in solution in water. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.
  • Huq, F., Beale, P., Yu, J. (2001). Studies on new tumour-active metal complexes. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.

2014

  • Hamad, S., Beale, P., Yu, J., Huq, F. (2014). Synthesis and Antitumour Activity of a New Trinuclear Platinum Compound [{cis-PtCI(NH3)2u {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] CI4 in Human Ovarian Cancer Cells. Anticancer Research, 34(4), 1923-1929.

2013

  • Yunos, N., Mutalip, S., Jauri, M., Yu, J., Huq, F. (2013). Anti-proliferative and Pro-apoptotic Effects from Sequenced Combinations of Andrographolide and Cisplatin on Ovarian Cancer Cell Lines. Anticancer Research, 33(10), 4365-4371. [More Information]
  • Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2013). Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumor models. Journal of Ovarian Research, 6(Nov 2013), 1-11. [More Information]
  • Lal, B., Badshah, A., Altaf, A., Tahir, M., Ullah, S., Huq, F. (2013). Study of new ferrocene incorporated N,N'-disubstituted thioureas as potential antitumour agents. Australian Journal of Chemistry: an international journal for chemical science, 66(11), 1352-1360. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2013). Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models. Medicinal Chemistry, 9(4), 539-544. [More Information]

2012

  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells. Anticancer Research, 32(1), 53-59. [More Information]
  • Mazumder, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Epigallocatechin Gallate Acts Synergistically in Combination with Cisplatin and Designed trans-palladiums in Ovarian Cancer Cells. Anticancer Research, 32(11), 4851-4860. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Studies on combination of platinum drugs Cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models. Anticancer Research, 32(11), 4843-4850. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Huq, F. (2012). Studies on the activity of two trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models. Anticancer Research, 32(12), 5331-5336. [More Information]
  • Hamad, S., Beale, P., Yu, J., Fisher, K., Huq, F. (2012). Synthesis and Activity of [{Cis-PtC1(NH3)2}2m{Trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]C14 in the human ovarian tumour models. Medicinal Chemistry, 8(3), 384-391. [More Information]
  • Mazumder, M., Beale, P., Chan, C., Yu, J., Huq, F. (2012). Synthesis and Cytotoxicity of Three trans-Palladium Complexes Containing Planaramine Ligands in Human Ovarian Tumor Models. ChemMedChem: chemistry enabling drug discovery, 7(10), 1840-1846. [More Information]
  • Deqnah, N., Yu, J., Beale, P., Fisher, K., Huq, F. (2012). Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models. Anticancer Research, 32(1), 135-140. [More Information]
  • Lal, B., Badshah, A., Altaf, A., Tahir, M., Ullah, S., Huq, F. (2012). Synthesis, characterization and antitumor activity of new ferrocene incorporated N,N′-disubstituted thioureas. Dalton Transactions: an international journal of inorganic, organometallic and bioinorganic chemistry, 41(48), 14643-14650. [More Information]

2011

  • Al-Shuneigat, J., Mahgoub, S., Huq, F. (2011). Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study. Journal of Biomedical Science, 18(Article number 50), 50-1-50-5. [More Information]
  • Al-Eisawi, Z., Beale, P., Chan, C., Yu, J., Huq, F. (2011). Modulation of Cisplatin Cytotoxicity due to its Combination with Bortezomib and the Nature of its Administration. Anticancer Research, 31(9), 2757-2762. [More Information]
  • Al-Shuneigat, J., Qing, Y., Beale, P., Fisher, K., Huq, F. (2011). Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3). Medicinal Chemistry, 7(1), 1-8. [More Information]
  • Alshehri, A., Beale, P., Yu, J., Huq, F. (2011). Synergism from Combination of Cisplatin and Multicentred Platinums Coded as DH6Cl and TH1 in the Human Ovarian Tumour Models. Medicinal Chemistry, 7(6), 593-598. [More Information]
  • Yunos, N., Beale, P., Yu, J., Huq, F. (2011). Synergism from Sequenced Combinations of Curcumin and Epigallocatechin-3-gallate with Cisplatin in the Killing of Human Ovarian Cancer Cells. Anticancer Research, 31(4), 1131-1140. [More Information]
  • Yunos, N., Beale, P., Yu, J., Huq, F. (2011). Synergism from the Combination of Oxaliplatin with Selected Phytochemicals in Human Ovarian Cancer Cell Lines. Anticancer Research, 31(12), 4283-4289. [More Information]
  • Nessa, M., Beale, P., Chan, C., Yu, J., Huq, F. (2011). Synergism from Vombinations of Cisplatin and Oxaliplatin with Quercetin and Thymoquinone in Human Ovarian Tumour Models. Anticancer Research, 31(11), 3789-3797. [More Information]
  • Huq, F., Danish, M., Starosta, W., Leciejewicz, J. (2011). trans-Bis(3-hydroxypyridine-jN)- diiodidoplatinum(II) dimethyl sulfoxide disolvate. Acta Crystallographica. Section E: Structure Reports Online, 67(6), m721-sup-7. [More Information]

2010

  • Yunos, N., Beale, P., Yu, J., Strain, D., Huq, F. (2010). Studies on combinations of platinum with Paclitaxel and colchicine in ovarian cancer cell lines. Anticancer Research, 30(10), 4025-4037. [More Information]
  • Al-Shuneigat, J., Yu, J., Beale, P., Fisher, K., Huq, F. (2010). Studies on Two New mixed Ligand Platinum Compounds with a Trans-Geometry. Medicinal Chemistry, 6(5), 321-328. [More Information]
  • Alshehri, A., Beale, P., Yu, J., Huq, F. (2010). Synergism from combination of Cisplatin and a trans-platinum compound in ovarian cancer cell lines. Anticancer Research, 30(11), 4547-4553. [More Information]

2009

  • Huq, F., Beale, P., Yu, J. (2009). Studies on New Platinum Compounds. In Andrea Bonetti, Roberto Leone,Franco M Muggia, Stephen B Howell (Eds.), Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications, (pp. 11-17). US: Humana Press.
  • Farhad, M., Yu, J., Beale, P., Fisher, K., Huq, F. (2009). Studies on the synthesis and activity of three tripalladium complexes containing planaramine ligands. ChemMedChem: chemistry enabling drug discovery, 4(11), 1841-1849. [More Information]
  • Huq, F., Tayyem, H., Yu, J., Beale, P., Fisher, K. (2009). Synthesis, activity and binding with DNA of [{trans-PtCl(NH3)2}2mu-{trans-Pd(4-hydroxypyridine)2(H2N(CH2)6NH2)2]Cl4 (TH8). Medicinal Chemistry, 5(4), 372-381. [More Information]

2008

  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Ambroxol. Journal of Pharmacology and Toxicology, 3(2), 147-152.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Entecavir. Journal of Pharmacology and Toxicology, 3(1), 41-46.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Maraviroc. Asian Journal of Biochemistry, 3(2), 79-89.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Methimazole. Journal of Pharmacology and Toxicology, 3(1), 11-19.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Ramelteon. Journal of Pharmacology and Toxicology, 3(2), 119-126.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Rasagiline. Journal of Pharmacology and Toxicology, 3(2), 168-172.
  • Huq, F., Fasim, F. (2008). Molecular Modelling Analysis of The Metabolism of Strychnine. International Journal of Pure and Applied Chemistry, 3(4), 241-246.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Terbinafine. Journal of Pharmacology and Toxicology, 3(2), 64-74.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Udenafil. Asian Journal of Biochemistry, 3(2), 109-117.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Venlafaxine. Journal of Pharmacology and Toxicology, 3(1), 27-33.
  • Huq, F. (2008). Molecular Modelling Analysis of the Metabolism of Zolpidem. Journal of Pharmacology and Toxicology, 3(2), 93-101.
  • Tayyem, H., Huq, F., Yu, J., Beale, P., Fisher, K. (2008). Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH(3))(2)}(2)mu-{trans-Pt(3-hydroxypyridine)(2)(H(2)N(CH(2))(6)NH(2))(2)}]Cl(4) in ovarian cancer cell lines. ChemMedChem: chemistry enabling drug discovery, 3(1), 145-151. [More Information]

2007

  • Huq, F. (2007). A Molecular Modelling Analysis of Luliconazole, Lanconazole and Bifonazole. Journal of Pharmacology and Toxicology, 2(6), 567-573.
  • Huq, F. (2007). A Molecular Modelling Analysis of the Metabolism of Mexiletine. Journal of Pharmacology and Toxicology, 2(7), 638-645.
  • Huq, F., Yunos, N. (2007). A Molecular Modelling Analysis of the Toxicity of Aflatoxin B1 and its Modulation by Chlorophyllin. International Journal of Pure and Applied Chemistry, 2(4), 371-376.
  • Huq, F. (2007). A Molecular Modelling Analysis of Toxicity of Fosamax and Risedronate. Journal of Pharmacology and Toxicology, 2(5), 489-495.
  • Huq, F. (2007). Metabolic Activation of Chloroform-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 37-42.
  • Huq, F. (2007). Metabolic Activation of Paracetamol-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 43-49.
  • Huq, F. (2007). Metabolic Activation of Toluene-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 105-120.
  • Huq, F. (2007). Metabolism of isoniazid – a molecular modelling analysis. International Journal of Pure and Applied Chemistry, 2(1), 1-9.
  • Huq, F. (2007). Metabolism of Ketoprofen-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(2), 229-234.
  • Huq, F. (2007). Metabolism of Mefenamic Acid-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 121-126.
  • Huq, F. (2007). Metabolism of Niclosamide-A Molecular Modelling Analysis. International Journal of Pure and Applied Chemistry, 2(1), 77-83.
  • Huq, F. (2007). Metabolism of vinyl chloride – a molecular modelling analysis. International Journal of Pure and Applied Chemistry, 2(1), 11-18.
  • Huq, F. (2007). Modular modelling analysis of the o-, m- and p-directing influences of substituents in electrophilic attack on aromatic compounds. Asian Journal of Chemistry, 19(1), 55-66.
  • Huq, F. (2007). Molecular modeling analysis of the metabolism of tarceva. International Journal of Pure and Applied Chemistry, 2(3), 281-287.
  • Huq, F. (2007). Molecular modelling analyses of the dimerization of acetic acid in non-polar solvents. Asian Journal of Chemistry, 19(1), 27-33.
  • Huq, F. (2007). Molecular Modelling Analyses of the Metabolism of Clofarabine. Journal of Pharmacology and Toxicology, 2(7), 599-609.
  • Huq, F. (2007). Molecular modelling analyses of the relative stability of alkenes, arenes and their epoxides and diols. Asian Journal of Chemistry, 19(1), 39-48.
  • Huq, F. (2007). Molecular Modelling Analysis of the Antioxidant Activity of Probucol. Asian Journal of Biochemistry, 2(5), 354-358.
  • Huq, F. (2007). Molecular Modelling Analysis of the Formation of HX.H2O Aggregates and (HX)n Oligomers where X = F, Cl, Br and I. International Journal of Pure and Applied Chemistry, 2(1), 19-25.
  • Huq, F., Ababneh, D. (2007). Molecular Modelling Analysis of the Metabolic Activation of Ethylene Glycol. Journal of Pharmacology and Toxicology, 2(1), 54-62.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Anagrelide. International Journal of Cancer Research, 3(1), 33-38.
  • Huq, F., Yunos, N. (2007). Molecular Modelling Analysis of the Metabolism of Andrographolide. International Journal of Pure and Applied Chemistry, 2(4), 359-369.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Aniracetam. Asian Journal of Biochemistry, 2(3), 164-171.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of aspirin. Asian Journal of Chemistry, 19(1), 102-108.
  • Huq, F., Ababneh, D., Alshehri, A. (2007). Molecular modelling analysis of the metabolism of carbamazepine. International Journal of Pure and Applied Chemistry, 2(2), 235-243.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of carbon tetrachloride. International Journal of Pure and Applied Chemistry, 2(1), 85-91.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Ceftiofur. Journal of Pharmacology and Toxicology, 2(4), 340-349.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Clotrimazole. Journal of Pharmacology and Toxicology, 2(8), 748-752.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Cocaine. Journal of Pharmacology and Toxicology, 2(2), 114-130.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of diflunisal. International Journal of Pure and Applied Chemistry, 2(2), 191-196.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of duloxetine. International Journal of Pure and Applied Chemistry, 2(3), 297-302.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Enoxacin. Journal of Pharmacology and Toxicology, 2(3), 284-289.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Eszopiclone. Journal of Pharmacology and Toxicology, 2(8), 732-736.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Fenbufen. Asian Journal of Biochemistry, 2(1), 50-57.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Fentanyl. Journal of Pharmacology and Toxicology, 2(2), 176-182.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Irbesartan. Journal of Pharmacology and Toxicology, 2(3), 238-247.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Latanoprost. Journal of Pharmacology and Toxicology, 2(4), 359-365.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of Loxapine. International Journal of Pure and Applied Chemistry, 2(2), 183-189.
  • Huq, F. (2007). Molecular modelling Analysis of the Metabolism of Lumiracoxib. International Journal of Pure and Applied Chemistry, 2(4), 377-385.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Mefenamic Acid. Journal of Pharmacology and Toxicology, 2, 72-79.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Meropenem. Journal of Pharmacology and Toxicology, 2(3), 295-299.
  • Huq, F., Al-Shuneigat, J. (2007). Molecular Modelling Analysis of the Metabolism of Methadone. Asian Journal of Biochemistry, 2(1), 19-30.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of methamphetamine. International Journal of Pure and Applied Chemistry, 2(1), 27-35.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of mifepristone. International Journal of Pure and Applied Chemistry, 2(2), 175-181.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of mirtazapine. International Journal of Pure and Applied Chemistry, 2(3), 289-296.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Naphthalene. Journal of Pharmacology and Toxicology, 2, 33-43.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of Nefazodone. International Journal of Pure and Applied Chemistry, 2(2), 155-165.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Paracetamol. Journal of Pharmacology and Toxicology, 2(2), 142-150.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of phenytoin. Journal of Pharmacology and Toxicology, 2(1), 63-71.
  • Huq, F., Al-Qassab, S. (2007). Molecular modelling analysis of the metabolism of raloxifene. International Journal of Pure and Applied Chemistry, 2(2), 197-204.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of scopolamine. International Journal of Pure and Applied Chemistry, 2(3), 271-280.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Tegaserod. Journal of Pharmacology and Toxicology, 2(5), 447-455.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Thiabendazole. Journal of Pharmacology and Toxicology, 2(6), 524-532.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Tolterodine. Journal of Pharmacology and Toxicology, 2(4), 319-327.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Toluene. Journal of Pharmacology and Toxicology, 2(1), 20-32.
  • Huq, F. (2007). Molecular modelling analysis of the metabolism of Trilostane. International Journal of Pure and Applied Chemistry, 2(4), 353-358.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Troglitazone. Asian Journal of Biochemistry, 2(4), 256-262.
  • Huq, F. (2007). Molecular Modelling Analysis of the Metabolism of Zileuton. International Journal of Pure and Applied Chemistry, 2(3), 263-269.
  • Huq, F. (2007). Structure of Hexakis(trimethylsilylmethyl)dimolybdenum: The First Compound Reported to have a Mo Mo Bond. Asian Journal of Chemistry, 19(1), 49-54.

2006

  • Huq, F. (2006). A molecular modelling analysis of why DDT and its metabolites have prolonged persistence in the environment and the living systems. International Journal of Pure and Applied Chemistry, 1(2), 191-196.
  • Huq, F., Abdullah, A., Beale, P. (2006). Antitumour activity of cis-bis{imidazo(1,2-alpha)pyridineplatinum(II). International Journal of Cancer Research, 2(4), 367-375.
  • Ababneh, D., Oakes, D., Huq, F. (2006). Evaluation of the genotoxic potential of cadmium and vitamin C against purified plasmid DNA and cellular DNA. Australian Health and Medical Research Congress, Melbourne: Australian Health and Medical Research Congress.
  • Farhad, M., Huq, F., Sivanandasingham, P. (2006). In vitro studies on DNA damage due to mixtures of ascorbate and iron(II). International Journal of Pure and Applied Chemistry, 1(2), 197-203.
  • Cheng, H., Chowdhury, A., Huq, F. (2006). Interaction between Ag+, nucleobases and nucleotides in solution. Asian Journal of Chemistry, 18(1), 37-44.
  • Huq, F. (2006). Metabolism of nicotine: a molecular modelling analysis. International Journal of Pure and Applied Chemistry, 1(3), 315-322.
  • Huq, F., Peter, M. (2006). Molecular mechanics and semi-empirical analyses of the interaction between Nickel(II) and L-histidine and L-arginine in solution in water. Asian Journal of Chemistry, 18(1), 45-49.
  • Huq, F., Peter, M. (2006). Molecular mechanics and semi-empirical analysis of the interaction between Co2+ and the amino acids in solution in water. Asian Journal of Chemistry, 18(1), 79-85.
  • Huq, F. (2006). Molecular modelling analysis of metabolism of styrene. International Journal of Pure and Applied Chemistry, 1(3), 371-378.
  • Huq, F. (2006). Molecular modelling analysis of the axial distortion of the coordination geometry around copper(II) in octahedral ligand fields. Asian Journal of Chemistry, 18(3), 1633-1636.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of adefovir dipivoxil. Journal of Pharmacology and Toxicology, 1(4), 362-368.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of caffeine. Asian Journal of Biochemistry, 1(4), 276-286.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of chloroform. Journal of Pharmacology and Toxicology, 1(5), 438-446.
  • Huq, F., Hossain, Z. (2006). Molecular modelling analysis of the metabolism of chlorpromazine. International Journal of Pure and Applied Chemistry, 1(1), 15-21.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of cocaine. International Journal of Pure and Applied Chemistry, 1(3), 323-330.
  • Huq, F., Al-Shuneigat, J. (2006). Molecular modelling analysis of the metabolism of codeine. Journal of Pharmacology and Toxicology, 1(5), 407-417.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of dacarbazine. International Journal of Pure and Applied Chemistry, 1(1), 31-36.
  • Huq, F., Hossain, Z. (2006). Molecular modelling analysis of the metabolism of diazepam. International Journal of Pure and Applied Chemistry, 1(1), 23-29.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of enrofloxacin. Asian Journal of Biochemistry, 1(4), 316-324.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of hydrazine. Journal of Pharmacology and Toxicology, 1(5), 485-489.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of ibuprofen. Journal of Pharmacology and Toxicology, 1(5), 456-463.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of isoniazid. Journal of Pharmacology and Toxicology, 1(5), 447-455.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of letrozole. International Journal of Cancer Research, 2(4), 403-408.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of maprotiline. Journal of Pharmacology and Toxicology, 1(6), 537-544.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of modafinil. Journal of Pharmacology and Toxicology, 1(4), 369-375.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of morphine. International Journal of Pure and Applied Chemistry, 1(3), 349-357.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of naltrexone. Journal of Pharmacology and Toxicology, 1(4), 354-361.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of naproxen. Journal of Pharmacology and Toxicology, 1(4), 346-353.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of niclosamide. Journal of Pharmacology and Toxicology, 1(4), 376-382.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of nitroimidazoles. International Journal of Pure and Applied Chemistry, 1(2), 147-153.
  • Huq, F., Hossain, Z. (2006). Molecular modelling analysis of the metabolism of pyrazinamide. Journal of Pharmacology and Toxicology, 1(6), 505-515.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of quazepam. International Journal of Pure and Applied Chemistry, 1(2), 141-146.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of sildenafil. International Journal of Pure and Applied Chemistry, 1(3), 339-347.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of sulindac. International Journal of Pure and Applied Chemistry, 1(2), 165-169.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of tamoxifen. International Journal of Pure and Applied Chemistry, 1(2), 155-163.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of topotecan. International Journal of Cancer Research, 2(4), 390-396.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of vinyl chloride. Journal of Pharmacology and Toxicology, 1(4), 299-316.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of zaleplon. Journal of Pharmacology and Toxicology, 1(4), 328-336.
  • Huq, F. (2006). Molecular modelling analysis of the metabolism of zebularine. Journal of Pharmacology and Toxicology, 1(4), 317-327.
  • Huq, F. (2006). Semi-empirical and DFT Analyses of the Metabolism of Hydrazine. International Journal of Pure and Applied Chemistry, 1(4), 455-459.
  • Huq, F., Farhad, M., Abdullah, A., Beale, P., Zhang, M. (2006). Studies on Oligonuclear Palladium Complexes. Asian Journal of Chemistry, 18(3), 1607-1625.
  • Huq, F., Tayyem, H., Beale, P., Yu, J. (2006). Studies on the activity of three palladium(II) compounds of the form: Trans-PdL(2)Cl(2) where L=2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine. Journal of Inorganic Biochemistry, 101(1), 30-35. [More Information]
  • Huq, F., Abdullah, A., Chowdhury, A., Tayyem, H., Beale, P., Fisher, K. (2006). Studies on the synthesis and characterization, and binding with DNA of two Cis-Planaramineplatinum(II) complexes of the forms: Cis-PtL2Cl2 and Cis-PtL(NH3)Cl2 and where L=3-hydroxypyridine and imidazo(1,2-αlpha) Pyridine. International Journal of Pure and Applied Chemistry, 1(1), 91-100.
  • Huq, F., Abdullah, A., Chowdhury, A., Cheng, H., Tayyem, H., Beale, P. (2006). Studies on the synthesis and characterization, binding with DNA and activity of cis-Bis{imidazo(1,2-alpha)-pyridine}dichloroplatinum(II). Asian Journal of Chemistry, 18(3), 1637-1648.
  • Huq, F., Abdullah, A., Beale, P., Yu, J., Zhang, M. (2006). Studies on the synthesis, characterization and binding with DNA of cis-bis (2,3-diaminopyridine) diiodoplatinum (II): A compound with high cell uptake and drug-DNA binding but very little activity. International Journal of Pure and Applied Chemistry, 1(2), 205-211.
  • Abdullah, A., Huq, F., Chowdhury, A., Tayyem, H., Beale, P., Fisher, K. (2006). Studies on the synthesis, characterization, binding with DNA and activities of two cis-planaramineplatinum(II) complexes of the form:cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine. BMC Chemical Biology, 6, 3-1-3-9. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Beale, P., Fisher, K. (2006). Syntheses and Characterisation of Four Trinuclear Complexes of The Form: [{Trans-Ptcl(NH3)2}2m-{Trans-Pd(NH3)2(H2N(CH2)Nnh2)2]Cl4 Where N = 4 to 7. International Journal of Pure and Applied Chemistry, 1(4), 493-507.
  • Huq, F., Tayyem, H., Abdullah, A., Beale, P., Fisher, K. (2006). Synthesis and Characterization and Binding of Amine-Palladium(II) Complexes and their Interaction with DNA. Asian Journal of Chemistry, 18(1), 65-78.
  • Cheng, H., Huq, F., Beale, P., Fisher, K. (2006). Synthesis, characterisation, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}2µ-{trans-Pd(NH3)(2-hydroxypyridine)-(H2N(CH2)6NH2)2]Cl4. European Journal of Medicinal Chemistry, 41(7), 896-903. [More Information]
  • Huq, F., Hossain, Z. (2006). Vitamin C causes a much-pronounced damage to DNA in presence of Cd2+ but not in presence of Zn2+ or Ag+. Why? Asian Journal of Chemistry, 18(3), 1649-1658.

2005

  • Cheng, H., Huq, F., Farhad, M. (2005). Interaction between Cu(II) and the neucleobases in solution. Asian Journal of Chemistry, 17(3), 1532-1538.
  • Huq, F. (2005). Molecular mechanics and semi-empirical analyses of the interaction between Cu(II) and amino acids in solution. Asian Journal of Chemistry, 17(3), 1550-1558.
  • Chowdhury, M., Huq, F., Abdullah, A., Beale, P., Fisher, K. (2005). Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the forms: trans-PtL2Cl2 and [PtL3Cl]Cl, where L = 3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-alpha)pyridine. Journal of Inorganic Biochemistry, 99(5), 1098-1112. [More Information]
  • Cheng, H., Huq, F., Beale, P., Fisher, K. (2005). Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH3)}(2)mu-{trans-Pt(NH3)(2-hydroxypyridine)-(H2N(CH2)(6)NH2)(2)]Cl-4. European Journal of Medicinal Chemistry, 40(8), 772-781. [More Information]
  • Huq, F. (2005). Why the lower-membered alkanoic acids are infinitely soluble in water whereas the higher-membered ones have a low solubility in water? A molecular modeling analysis. Asian Journal of Chemistry, 17(2), 1001-1012.

2004

  • Daghriri, H., Huq, F., Beale, P. (2004). 'Studies On Activities, Cell Uptake And Dna Binding Of Four Multinuclear Complexes Of The Form: [{Trans-Ptcl(Nh3)2}2U-{Trans-Pd(Nh3)2-(H2N(Ch2)Nnh2)2}]Cl4 Where N = 4-7'. Journal of Inorganic Biochemistry, 98(11), 1722-1733. [More Information]
  • Huq, F., Yu, J., Daghriri, H., Beale, P. (2004). Studies On Activities, Cell Uptake And Dna Binding Of Four Trans-Planaramineplatinum(Ii) Complexes Of The Form: Trans-Ptl(Nh3)Cl-2,Where L=2-Hydroxypyridine, Imidazole, 3-Hydroxypyridine And Imidazo(1,2-Alpha)Pyridine. Journal of Inorganic Biochemistry, 98(8), 1261-1270. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Beale, P., Fisher, K. (2004). Studies On The Synthesis And Characterization Of Four Trans-Planaramineplatinum(Ii) Complexes Of The Form Trans-Ptl(Nh3)Cl2 Where L = 2-Hydroxypyridine, 3-Hydroxypyridine, Imidazole, And Imidazo(1,2-Alpha)Pyridine. European Journal of Medicinal Chemistry, 39(8), 691-697. [More Information]
  • Huq, F., Daghriri, H., Yu, J., Tayyem, H., Beale, P., Zhang, M. (2004). Synthesis, Characterisation, Activities, Cell Uptake And Dna Binding Of [{Trans-Ptcl(Nh3)2} {U-(H2N(Ch2)6Nh2)} {Trans-Pdcl(Nh3)2](No3)Cl. European Journal of Medicinal Chemistry, 39(11), 947-958. [More Information]

2002

  • Mousa, K., Mahajan, D., Huq, F., Bermingham, M. (2002). Body fat ratio and BMI in a group of Bangladeshi residents in Australia. From Cell to Society 3, : British Medical Journal Publishing Group.
  • Huq, F., Yu, J. (2002). Molecular modeling analysis: "why is 2-hydroxypyridine soluble in water but not 3-hydroxypyridine?". Journal of Molecular Modeling, 8(3), 81-86. [More Information]
  • Beale, P., Daghriri, H., Huq, F. (2002). Studies on anticancer active heteronuclear metal complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Abdullah, A., Beale, P., Huq, F. (2002). Studies on planaramineplatinum (II) complexes with cis-geometry. Third Research Conference 2002 From Cell to Society, : British Medical Journal Publishing Group.
  • Beale, P., Cheng, H., Huq, F. (2002). Studies on polynuclear complexes with different coordination geometries. From Cell to Society 3, : British Medical Journal Publishing Group.
  • Beale, P., Huq, F., Mohammad, F. (2002). Studies on polynuclear palladium complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Bibi, M., Huq, F., Sivanandasingham, P. (2002). Studies on the antioxidant and prooxidant behaviour of ascorbate in presence of iron. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Hossain, Z., Huq, F. (2002). Studies on the interaction between Ag+ and DNA. Journal of Inorganic Biochemistry, 91(2), 398-404.
  • Hossain, Z., Huq, F. (2002). Studies on the interaction between Cd2+ and nucleobases and nucleotides. Journal of Inorganic Biochemistry, 90(3-4), 97-105.
  • Hossain, Z., Huq, F. (2002). Studies on the interaction between Cd2+ ions and DNA. Journal of Inorganic Biochemistry, 90(3-4), 85-96.
  • Yu, J., Beale, P., Huq, F. (2002). Studies on transplanaramineplatinum (II) complexes. Third Research Conference 2002 From Cell to Society 3, : British Medical Journal Publishing Group.
  • Mousa, K., Mahajan, D., Huq, F., Bermingham, M. (2002). The relationship between percent TBF and BMI in a Bangladeshi population sample in Australia. Proceedings of the Australian Health and Medical Research Congress 2002, : British Medical Journal Publishing Group.

2001

  • Hossain, Z., Huq, F. (2001). Changes in adenine and adenine nucleotides due to their interaction with Cd2+ ions. Redox Processes in Chemistry, Biology and Medicine, : Ads & Adea.
  • Hossain, Z., Huq, F. (2001). Increased DNA damage due to cooperative interaction between Cd2+ and antioxidants. Redox Processes in Chemistry, Biology and Medicine, : Ads & Adea.
  • Huq, F., Mohammad, F. (2001). Modelling the interaction between Cu2+ and the nucleobases adenine and guanine in solution in water. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.
  • Huq, F. (2001). Molecular modeling analysis of the ease in oxidation of planar nickel-peptide complexes. Journal of Molecular Modeling, 7, 433-437.
  • Huq, F., Beale, P., Yu, J. (2001). Studies on new tumour-active metal complexes. 10th International Conference on Bioinorganic Chemistry, : Ads & Adea.

To update your profile click here. For support on your academic profile contact .